99 related articles for article (PubMed ID: 5894619)
1. [Administration of large doses of mitomycin C during stomach cancer surgery. Postoperative survival rates following palliative resection].
Hattori T; Ito I; Hirata K; Iizuka T; Abe K
Gan No Rinsho; 1965 Nov; 11(12):817-26. PubMed ID: 5894619
[No Abstract] [Full Text] [Related]
2. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
[TBL] [Abstract][Full Text] [Related]
3. [Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].
Hiratsuka M; Ogawa A; Ohigashi H; Kameyama M; Sasaki Y; Ishikawa O; Kabuto T; Fukuda I; Furukawa H; Imaoka S
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1574-9. PubMed ID: 3141534
[No Abstract] [Full Text] [Related]
4. [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)].
Muto T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Nakajima T; Kikuchi K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1863-70. PubMed ID: 6433808
[TBL] [Abstract][Full Text] [Related]
5. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
[TBL] [Abstract][Full Text] [Related]
7. Follow-up study on gastric cancer treated with mitomycin C prior to surgical operation.
Sakakibara N; Okajima K; Okumura S
Acta Med Okayama (1952); 1966 Aug; 20(4):175-9. PubMed ID: 4226978
[No Abstract] [Full Text] [Related]
8. [Combined administration of mitomycin C for the improved management of stomach neoplasms].
Kakuta H; Kikuchi A; Nagano S; Machida S; Fukushima M; Ishikawa Y
Nihon Rinsho; 1978 Jun; 36(6):2576-80. PubMed ID: 359865
[No Abstract] [Full Text] [Related]
9. [Study on the combined therapy of surgery and mitomycin C administration for stomach cancer].
Ishikawa Y; Kakuta H; Komaba M; Sato K; Yagihashi H
Geka Chiryo; 1969 May; 20(5):488-95. PubMed ID: 5820209
[No Abstract] [Full Text] [Related]
10. Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and-or allogeneic bone marrow transplantation.
Hattori T; Mori A; Hirata K; Ito I
Gan; 1972 Oct; 63(5):517-22. PubMed ID: 4566613
[No Abstract] [Full Text] [Related]
11. [Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report].
Abe O; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Ito I; Nakajima T; Muto T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2408-17. PubMed ID: 6416184
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J; Kikuchi H
Naika; 1966 Jun; 17(6):1101-15. PubMed ID: 5964528
[No Abstract] [Full Text] [Related]
13. [Prolonged intra-arterial administration of antineoplastic agents after surgery of stomach cancer. Suggestion for massive intermittent administration over a long period].
Honda K; Koseki M; Shiota Y; Kawamura T; Okuyama T
Gan No Rinsho; 1969 Mar; 15(3):327-31. PubMed ID: 5816308
[No Abstract] [Full Text] [Related]
14. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
16. [Cancer chemotherapy in the field of surgery--with special reference to stomach cancer].
Hattori T; Niimoto M; Oride M
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1041-9. PubMed ID: 6408996
[TBL] [Abstract][Full Text] [Related]
17. [Conditions suitable for the adjuvant chemotherapy of gastric cancer].
Nakajima T; Takahashi T; Takagi K; Kuno K; Kajitani T
Gan No Rinsho; 1983 Aug; 29(10):1229-36. PubMed ID: 6415314
[TBL] [Abstract][Full Text] [Related]
18. [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].
Kondo T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Kasai Y; Sugie S; Hayasaka A
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2016-24. PubMed ID: 6820887
[TBL] [Abstract][Full Text] [Related]
19. [Case of unresectable gastric cancer for wich splenectomy was performed because massive administration of mitomycin C did not reduce the number of leukocytes].
Ono K; Shimano M
Gan No Rinsho; 1968 Oct; 14(10):874-8. PubMed ID: 5750972
[No Abstract] [Full Text] [Related]
20. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
Paolucci R
Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
